Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Other notable examples include a $1.3 billion partnership between Novartis and Dunad Therapeutics spanning four targets, a $1.6 billion deal between Eli Lilly and Lycia focusing on up to five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback